Corbion (ENXTAM:CRBN) moved into focus after CEO Olivier Rigaud informed the Supervisory Board that he will step down at the end of his current term in May 2027.
Corbion shares have climbed over the year, with a year to date share price return of 17.57% and a 1 year total shareholder return of 38.77%. However, the 5 year total shareholder return is down 37.36%, which suggests recent momentum has picked up after a weaker longer run.
Scan how Corbion compares with other materials-focused businesses going through change by checking our hand-picked list of solid balance sheet and fundamentals (206 results).
Bulls view Corbion’s recent share price recovery and earnings growth as a reset. Bears highlight the weaker 5-year return and an upcoming CEO change. Which side do current fundamentals support?
Most Popular Narrative: 8% Undervalued
Corbion last closed at €22.08, while the most followed narrative points to a fair value near €24.03. This frames the recent share price recovery as still leaving some valuation gap on the table.
Ramp-up of the new gypsum-free lactic acid plant in Thailand is expected to significantly boost production capacity and operating efficiency. This is anticipated to enable Corbion to meet rising demand for biobased chemicals and food preservation solutions, positively impacting revenue and EBITDA margins through improved scale and lower unit costs.
See why 16 investors see Corbion as 8% undervalued.
Result: Fair Value of €24.03 (UNDERVALUED)
Still, the Corbion narrative hinges on demand and pricing holding up. Prolonged Biochemicals softness or weaker omega 3 contract terms are both capable of undercutting the upside case.
Find out about the key risks to this Corbion narrative.
Next Steps
Mixed signals around Corbion’s reset story can cut both ways. Move quickly, review the underlying data, then weigh the 2 key rewards and 2 important warning signs.
Looking for more investment ideas beyond Corbion?
Do not park your attention on Corbion alone. Fresh watchlist ideas often come from comparing this story with other stocks built on solid fundamentals and clear return drivers.
Use the Simply Wall St Screener to surface three very different sets of opportunities that could sharpen your next move.
- Target resilient balance sheets and steady fundamentals by scanning our list of solid balance sheet and fundamentals (206 results) while Corbion stays on your radar.
- Hunt for mispriced potential and compare Corbion's setup with a curated pool of 185 high quality undervalued stocks that may offer a margin of safety.
- Spot future market favourites early by reviewing a focused lineup of 614 high quality undiscovered gems before the wider crowd catches on.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com